News | October 01, 2025
Pfizer agrees to slash prescription drug prices for Americans
Pfizer will participate in TrumpRx.gov, a direct-to-patient purchasing platform offering discount up to 85%
Pfizer will participate in TrumpRx.gov, a direct-to-patient purchasing platform offering discount up to 85%
Hyperion results presented at ERS 2025 and simultaneously published in the New England Journal of Medicine
LEQEMBI was initially approved in China in January 2024 for the treatment of Alzheimer’s disease in patients with mild cognitive impairment
FDA authorization was based on two years of clinical study data demonstrating that Essilor Stellest lenses significantly slowed myopia progression compared to single-vision control lenses
The new site enables end-to-end production of viral vector gene therapies
Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
Prolia is a prescription medicine used to treat osteoporosis in women
The facility has been classified as Voluntary Action Indicated
The TULIP-SC trial investigated the efficacy and safety of subcutaneous Saphnelo
Includes new $1.2 billion investment in manufacturing facilities, AI and advanced digital technologies, creating hundreds of highly skilled U.S. jobs
Subscribe To Our Newsletter & Stay Updated
